Newsletter for primary market participants
March 2020/No. 27
About this edition
Welcome to the 27th edition of the Primary Market Bulletin (PMB). This is a special edition in which we provide key commentary for issuers and market participants in light of the coronavirus (Covid-19) pandemic.
We will keep these matters under consideration and will keep this information updated.
Our core focus at this time is to ensure consumers are protected and markets continue to function well. Equity and debt capital markets play a vital role providing finance to the real economy. In line with our market integrity objective, we want to maintain orderly markets and market integrity. To do this we want to ensure that appropriate disclosure continues. This will allow investors and the market to continue to price securities effectively.
Ongoing disclosure under the Market Abuse Regulation
Issuers should continue to comply with their obligations under the Market Abuse Regulation (MAR) and relevant FCA rules.
Issuers should be aware that their own operational response to coronavirus may itself meet the requirements for disclosure under MAR.
We are conscious that coronavirus may create challenges in the convening and operation of disclosure committees. However, we continue to expect listed issuers to make every effort to meet their disclosure obligations in a timely fashion.
In the short term, we appreciate there may be slight delays as new processes are put in place.
Market volatility and suspension of trading
Our aim is to continue to maintain open and orderly markets despite current volatility.
We will continue to consider requests from issuers to suspend trading in certain securities. In line with existing rules and practice, we will consider these requests according to our assessment of risks to the smooth operation of the market and the risk of harm to investors. This means we will challenge the need for suspension where we think the situation is more appropriately addressed by an announcement to the market.
Before submitting a request for suspension, issuers should ensure they have thoroughly examined the justification for this.
If you, as an issuer, think a request for suspension of listing is required to prevent a disorderly market, or to protect investors, contact the Primary Market Monitoring team emergency line on 020 7066 8354, or by email to [email protected].
The importance of transaction notifications
We expect persons discharging managerial responsibilities (PDMR), and ‘persons (who are) closely associated’, to continue to meet their notification requirements under MAR within the prescribed time frame.
Do this by submitting notifications through our electronic submission portal and dedicated mailboxes ([email protected]).
Delays in corporate reporting
We are conscious that coronavirus may create logistical issues when producing accounts for upcoming reporting periods.
We expect issuers to put in place contingency plans to minimise these impacts. Such planning could consider, for example, whether there are non-essential parts of their report and their reporting cycle they can deprioritise.
However, we and the FRC and PRA recognise the significant challenges issuers and their auditors face in preparing reports and accounts. As result the FCA, FRC and PRA have published a joint statement on corporate reporting during the coronavirus crisis.
The joint statement highlights measures all three bodies are taking in response to the crisis.
The FCA measures highlighted in the joint statement include temporary relief for issuers to publish their audited annual financial report within six months of the company’s year end.
An important supplementary Q&A has also been published.
If an issuer does not believe it is able to meet its continuing obligations it should take appropriate advice and advisors can contact the FCA to discuss. Issuers should engage with their auditors, who should contact the Financial Reporting Council (FRC), as appropriate.
We will continue to keep this under review, and liaise closely with the FRC, PRA and, where relevant, other bodies.
Corporate transactions and admissions
We will continue reviewing documentation for corporate transactions in line with the established principles set out on our website.
Where issuers are looking to carry out urgent transactions they should, in the first instance, engage with their relevant sponsor firm or adviser.